INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/23/2026
Back to search
Official data from USPTO
PALYNOX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PALYNOX
ST13
US500000079336509Class
5, 42, 44
Filing
79336509
Registration
7451810
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
02/24/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
10/19/2021
Registration date
07/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
02/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
01
Owner location
FR
Examiner
HOLLAND, JAMI ELENA
Current location
Historical data usage
Holders and representatives
Holders
M. S. (pessoa física)
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression excluding gases for medical use; phytopharmaceutical preparations for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression excluding gases for medical use; dietetic and homeopathic products for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression excluding gases for medical use; medical preparations for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression excluding gases for medical use; preparations for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression excluding gases for medical use; veterinary preparations for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression excluding gases for medical use; food and dietary supplements for humans and animals; dietetic food adapted for medical or veterinary use; food supplements consisting of vitamins; food supplements for pharmaceutical use; food supplements for animals; vitamin and mineral food supplements; pharmaceutical for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression sold on prescription or over the counter; veterinary preparations for pets for the treatment of allergies sold on prescription or over the counter; food supplements for pharmaceutical and veterinary use; natural food supplements for allergy treatment; chemical preparations for medical usefor the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression; chemical preparations for pharmaceutical usefor the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression; medicinal preparationsfor the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression; plant preparations for medical usefor the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression; the above-mentioned goods are not intented to be manufacturedcommercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy * the aforesaid goods are not intended to be manufacturedmarketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy *
Class 42
Scientific and technological servicesresearch in the fields of chemistrybiology and pharmacy; industrial research in the field of pharmaceutical preparations and food supplements for the treatment of allergiesocular disorders or diseasesprostate disorders or diseases and depression; industrial design services; quality control of goods and services in the field of pharmaceutical preparations; pharmaceutical research and development services; pharmaceutical research services; laboratory research services in the field of pharmaceuticals; the above-mentioned services are not intented to be manufacturedcommercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy * the aforesaid services are not intended to be manufacturedmarketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy *
Class 44
Health care for human beingsincluding dietetic and medical services; veterinary services; medical examination services; provision of information relating to dietary and nutritional supplements; consultancy in the pharmaceutical and healthcare services field; advice and information relating to the aforesaid services; advisory services relating to health care; hygienic and beauty care; the above-mentioned services are not intented to be manufacturedcommercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy * the aforesaid services are not intended to be manufacturedmarketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy *
Publications
History of USPTO decisions and trademark events.
50 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/10/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/06/2025
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
01/28/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/25/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/08/2025
FIMP
FINAL DISPOSITION PROCESSED
01/08/2025
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
01/06/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/15/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
06/14/2024
OP.T
OPPOSITION TERMINATED NO. 999999
06/14/2024
OP.D
OPPOSITION DISMISSED NO. 999999
06/14/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/28/2024
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
04/09/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/04/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/30/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/30/2023
RFNT
REFUSAL PROCESSED BY IB
08/01/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
07/11/2023
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
07/04/2023
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
07/04/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/27/2023
RFNP
REFUSAL PROCESSED BY IB
08/29/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/05/2022
RFRR
REFUSAL PROCESSED BY MPU
08/04/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2022
CNRT
NON-FINAL ACTION WRITTEN
08/01/2022
DOCK
ASSIGNED TO EXAMINER
07/26/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2022
Continuous trademark protection
Get notified about every new filing that threatens PALYNOX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.